Established in 1993, CMAX is one of Australia’s largest and most experienced clinical trial units, specialising in early-phase studies.
Our state-of-the-art, 78-bed facility in Adelaide’s Bio-Med City supports Phase I-II trials, with over 200 first-in-human studies completed.
With an impressive global regulatory history and a database of 55,000+ participants, we provide reliable, diverse participant recruitment for high-quality research.
All studies are ICH GCP compliant and meet the requirements of the US FDA, EMEA, Japan’s MHW, and Health Canada. We are also US FDA-audited.
Choose CMAX for high-quality clinical trials that set the benchmark for success.
Company Details
- Employees
- 196
- Founded
- -
- Address
- 21-24 North Terrace, Adelaide,sa 5000,australia
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- cmax.com.au
- Keywords
- Phase I - II clinical trial site, First in Human (FIH) clinical trials, Single and multiple ascending dose studies, Bioequivalence, bioavailability and pharmacokinetic studies, Biosimilar studies, Safety and efficacy studies.
- HQ
- Adelaide, SA
Cmax Clinical Research Questions
Cmax Clinical Research's website is cmax.com.au
Cmax Clinical Research's LinkedIn profile is https://au.linkedin.com/company/cmax-clinical-research-pty-ltd
Cmax Clinical Research has
196 employees.
View email and phone details for 196
employees at Cmax Clinical Research.
Cmax Clinical Research's industry is
Research Services
Cmax Clinical Research's top competitors are
Nucleus Network,
Southern Star Research,
Q-Max Clinical Research,
Emerald Clinical,
Scientia Clinical Research,
Linear Clinical Research,
Agilex Biolabs Pty Ltd,
Avance Clinical,
Sahmri,
Novotech.
Cmax Clinical Research's categories are Research Services
Cmax Clinical Research's founding year is 1993
